print this page decrease the text size increase the text size

Note for guidance on good clinical practice

CPMP/ICH/135/95

7 July 2000

The Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) is an internationally accepted standard for the designing, conducting, recording and reporting of clinical trials.

The TGA has adopted CPMP/ICH/135/95 in principle but has recognised that some elements are, by necessity, overridden by the National Statement (and therefore not adopted) and that others require explanation in terms of 'local regulatory requirements'.

How to access a pdf document

Note for guidance on good clinical practice (CPMP/ICH/135/95 - Annotated with TGA comments) (pdf,143kb)

Contents

  • Introduction
  1. Glossary
  2. The principles of ICH GCP
  3. Institutional review board / independent ethics committee (IRB/IEC)
  4. Investigator
  5. Sponsor
  6. Clinical trial protocol and protocol amendment(s)
  7. Investigator's brochure
  8. Essential documents for the conduct of a clinical trial

Content last updated: Tuesday, 25 July 2000

Content last reviewed: Friday, 25 March 2011

Web page last updated: Friday, 25 March 2011

URL: http://www.tga.gov.au/industry/clinical-trials-note-ich13595.htm

Site navigation

Safety information

Consumers

Health professionals

Industry

About the TGA

News room